Cite
HARVARD Citation
Slade, A. et al. (n.d.). FRI0230 Assessment of Safety, Pharmacokinetics and Pharmacodynamics of A Novel anti-CD40 Monoclonal antibody, CFZ533, in Healthy Volunteers and in Rheumatoid Arthritis Patients. Annals of the rheumatic diseases. pp. 516-517. [Online].